On ECHEMI
Home > Drugs > China Resources Zizhu Pharmaceutical Co., Ltd.
China Resources Zizhu Pharmaceutical Co., Ltd.
  • Founded in:

    1980-11-26
  • Country:

    China China
  • Address:

    Building 18, No. 27 Chaoyang North Road, Chaoyang District, Beijing
  • Tax NO.:

    91110000101939631P
  • Registered Funds:

    660.6396 million yuan
  • Website:

  • Email:

Related Drugs
Rauwolfia chips
This product is a total alkaloid preparation of Rauwolfia ovata, and its main component is reserpine.
Name Description Content CAS NO. Registered Holders
Reserpine

It depletes the norepinephrine storage in the peripheral sympathetic nerve terminals, and also depletes the catecholamine and 5-hydroxytryptamine storage in the brain, heart and other organs. The blood pressure reduction is mainly peripheral, the peripheral vascular resistance is reduced, the heart rate is slowed down, and the cardiac output is reduced, thereby lowering the blood pressure.

More

It depletes the norepinephrine storage in the peripheral sympathetic nerve terminals, and also depletes the catecholamine and 5-hydroxytryptamine storage in the brain, heart and other organs. The blood pressure reduction is mainly peripheral, the peripheral vascular resistance is reduced, the heart rate is slowed down, and the cardiac output is reduced, thereby lowering the blood pressure.

50-55-5 19
Theophylline sustained-release tablets
The main component of this product is theophylline, and its chemical name is: 1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione monohydrate. Molecular formula: C7H8N4O2H2O Molecular weight: 198.18.
Name Description Content CAS NO. Registered Holders
Theophylline

It has a direct relaxant effect on respiratory smooth muscle, partly by inhibiting phosphodiesterase to increase intracellular cAMP content, and partly as a result of the release of endogenous adrenaline and norepinephrine; as a purine receptor blocker, it can counteract the contractile effect of adenine and other substances on the respiratory tract; it can enhance the contractility of the diaphragm and improve respiratory function.

More

It has a direct relaxant effect on respiratory smooth muscle, partly by inhibiting phosphodiesterase to increase intracellular cAMP content, and partly as a result of the release of endogenous adrenaline and norepinephrine; as a purine receptor blocker, it can counteract the contractile effect of adenine and other substances on the respiratory tract; it can enhance the contractility of the diaphragm and improve respiratory function.

58-55-9 26
Praziquantel Tablets
Chemical name: 2-cyclohexylcarbonyl-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-α]isoquinolin-4-one, molecular formula: C19H24N2O2, molecular weight: 312.41.
Name Description Content CAS NO. Registered Holders
2-Cyclohexylcarbonyl-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-α]isoquinolin-4-one

It is effective against schistosomes, tapeworms, cysticercosis, Clonorchis sinensis, Paragonimus thoracis, and Fasciola gingivalis. It has two main pharmacological effects on the worm: 1. The muscles of the worm undergo tonic contraction and produce spastic paralysis; 2. The cortex of the worm is damaged and the host immune function is involved. In addition, praziquantel can also cause secondary changes, depolarizing the surface membrane of the worm, significantly reducing the activity of cortical alkaline phosphatase, inhibiting the uptake of glucose, depleting endogenous glycogen, and inhibiting the synthesis of nucleic acid and protein in the worm.

More

It is effective against schistosomes, tapeworms, cysticercosis, Clonorchis sinensis, Paragonimus thoracis, and Fasciola gingivalis. It has two main pharmacological effects on the worm: 1. The muscles of the worm undergo tonic contraction and produce spastic paralysis; 2. The cortex of the worm is damaged and the host immune function is involved. In addition, praziquantel can also cause secondary changes, depolarizing the surface membrane of the worm, significantly reducing the activity of cortical alkaline phosphatase, inhibiting the uptake of glucose, depleting endogenous glycogen, and inhibiting the synthesis of nucleic acid and protein in the worm.

0
Compound packaging of paracetamol and vitamin B1 paracetamol tablets
The light orange tablets contain 2 mg of chlorpheniramine maleate and 10 mg of vitamin B1; each reddish-brown tablet contains 4 mg of chlorpheniramine maleate and 100 mg of acetaminophen.
Name Description Content CAS NO. Registered Holders
Chlorphenamine maleate

It can counteract the capillary dilation caused by allergic reactions (histamine), reduce the permeability of capillaries, and alleviate the symptoms of runny nose, nasal congestion, sneezing, etc. caused by allergic rhinitis

More

It can counteract the capillary dilation caused by allergic reactions (histamine), reduce the permeability of capillaries, and alleviate the symptoms of runny nose, nasal congestion, sneezing, etc. caused by allergic rhinitis

2mg 113-92-8 28
Thiamine chloride

As one of the important components of coenzyme, it plays a synergistic role

More

As one of the important components of coenzyme, it plays a synergistic role

10mg 59-43-8 9
Acetaminophen

It can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects

More

It can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects

100mg 103-90-2 68
Ambroxol Hydrochloride Sustained Release Capsules
The main ingredient of this product is ambroxol hydrochloride.
Name Description Content CAS NO. Registered Holders
Ambroxol hydrochloride

This product is a mucolytic agent that can increase the secretion of serous glands in the respiratory mucosa and reduce the secretion of mucous glands, thereby reducing sputum viscosity, promoting the secretion of pulmonary surfactant, increasing bronchial ciliary movement, and making sputum easier to cough up.

More

This product is a mucolytic agent that can increase the secretion of serous glands in the respiratory mucosa and reduce the secretion of mucous glands, thereby reducing sputum viscosity, promoting the secretion of pulmonary surfactant, increasing bronchial ciliary movement, and making sputum easier to cough up.

23828-92-4 38
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.